Join clinical researcher Dr. Erika Comasco as she presents findings on ulipristal acetate (a selective progesterone modulator, SPRM) as a potential treatment for PMDD. This webinar covers results from the first multicenter randomized controlled trial, along with neuroimaging insights into how SPRMs may affect brain function and structure in PMDD.